SCM Lifescience Co., Ltd.
SCM Lifescience Co., Ltd. was founded in 2014 with a vision of treating incurable diseases by using the natural properties of adult stem cells. Developing stem cell products and providing new life to the patients with life-threatening diseases is our main goal and responsibility.
SCM Lifescience has obtained domestic and international patents on the isolation method for a highly pure population of mesenchymal stem cells [Korea(2008), USA(2010), Japan(2012), China(2013), Europe(2014)] and on manufacturing process for stem cell products [USA(2014)]. With these in-house technologies developed, we will manufacture stem cell therapeutics for the treatment of graft-versus-host disease, atopic dermatitis, pancreatitis, diabetes, asthma, and so on. We will also dedicate to the development technologies on regeneration of tissues, such as skin, bone, and cartilage, and organs in the field of regenerative medicine. In order to contribute to the advancement of stem cell field, we will carry out services for storage of personal adult stem cells, mass production of stem cell products for clinical trials, and supply of stem cell research-related products. SCM Lifescience will do it’s best to be a global leading entrepreneur in the stem cell/regenerative medicine field.